Production (Stage)
MedX Health Corp
MDXHF
$0.0008
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 175.20% | -19.90% | -55.44% | 117.58% | -68.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 175.20% | -19.90% | -55.44% | 117.58% | -68.88% |
| Cost of Revenue | 73.94% | 21.76% | -62.50% | 146.67% | -29.97% |
| Gross Profit | 3,386.67% | -48.88% | -46.40% | 71.74% | -98.32% |
| SG&A Expenses | -48.82% | -49.78% | -14.28% | -13.42% | -42.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -28.04% | -39.89% | -18.82% | 4.54% | -41.68% |
| Operating Income | 49.34% | 42.54% | 8.13% | 2.66% | 35.80% |
| Income Before Tax | -78.69% | 50.09% | 34.10% | 24.42% | 56.69% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -78.69% | 50.09% | 34.10% | 24.42% | 56.69% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -78.69% | 50.09% | 34.10% | 24.42% | 56.69% |
| EBIT | 49.34% | 42.54% | 8.13% | 2.66% | 35.80% |
| EBITDA | 48.26% | 43.92% | 8.07% | 1.12% | 37.18% |
| EPS Basic | -52.63% | 64.81% | 53.57% | 48.00% | 66.07% |
| Normalized Basic EPS | 25.00% | 64.71% | 54.29% | 48.39% | 31.43% |
| EPS Diluted | -52.63% | 64.81% | 53.57% | 48.00% | 66.07% |
| Normalized Diluted EPS | 25.00% | 64.71% | 54.29% | 48.39% | 31.43% |
| Average Basic Shares Outstanding | 16.01% | 43.43% | 43.72% | 42.57% | 26.35% |
| Average Diluted Shares Outstanding | 16.01% | 43.43% | 43.72% | 42.57% | 26.35% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |